Dr. Klotman serves as president, CEO and executive dean and oversees Baylor’s activities across its mission areas of education, research, patient care and community service. Previously, he served as chair of the Samuel Bronfman Department of Medicine at Mount Sinai School of Medicine, chief of the Viral Pathogenesis Laboratory at the National Institutes of Health and chief of the NIH Molecular Medicine Section of the Laboratory of Developmental Biology. An expert nephrologist, his research focuses on molecular biology and AIDS pathogenesis, and he developed the first animal model of HIV-associated nephropathy using transgenic techniques.
Dr. Klotman serves on the scientific advisory boards of biotech, pharmaceutical and healthcare companies as well as a number of nonprofits. He completed his medical degree and nephrology training at Duke University Medical Center, where he later served as an associate faculty member.